Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Resiquimod

EU orphan designation number: EU/3/16/1653   
Active ingredient: Resiquimod
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Galderma R&D
Les Templiers, 2400 route des Colles, 06410 Biot, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/05/2016 Orphan designation EMA/OD/254/15 (2016) 2739 of 28/04/2016